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Abstract
To address the functions of FGFR2 and FGFR3 signaling during mandibular skeletogenesis, we over-expressed in the developing chick
mandible, replication-competent retroviruses carrying truncated FGFR2c or FGFR3c that function as dominant negative receptors (RCAS-
dnFGFR2 and RCAS-dnFGFR3). Injection of RCAS-dnFGFR3 between HH15 and 20 led to reduced proliferation, increased apoptosis, and
decreased differentiation of chondroblasts in Meckel's cartilage. These changes resulted in the formation of a hypoplastic mandibular process and
truncated Meckel's cartilage. This treatment also affected the proliferation and survival of osteoprogenitor cells in osteogenic condensations,
leading to the absence of five mandibular bones on the injected side. Injection of RCAS-dnFGFR2 between HH15 and 20 or RCAS-dnFGFR3 at
HH26 did not affect the morphogenesis of Meckel's cartilage but resulted in truncations of the mandibular bones. RCAS-dnFGFR3 affected the
proliferation and survival of the cells within the periosteum and osteoblasts. Together these results demonstrate that FGFR3 signaling is required
for the elongation of Meckel's cartilage and FGFR2 and FGFR3 have roles during intramembranous ossification of mandibular bones.
© 2008 Elsevier Inc. All rights reserved.Keywords: GFR3; FGFR2; Chick mandible; Meckel's cartilage; Mandibular bones; RCASIntroduction
The development of the mandible is a dynamic multi-step
process that starts with the formation of mandibular processes
from the first branchial arch. At the time of their formation, the
mandibular processes consist of mesenchyme encased by
epithelium derived from ectoderm and endoderm. The skeletal
elements in the mandibular arch are made by cranial neural crest
cells (NCC) (reviewed by Chai andMaxson, 2006; Le Douarin et
al., 2004; Santagati and Rijli, 2003). Although NCCs provide
species-specific patterning information in the developing
branchial arch skeleton (Schneider and Helms, 2003; Tucker
and Lumsden, 2004), the fate and differentiation of NCCs⁎ Corresponding author. Division of Pediatric Dentistry, Department of
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doi:10.1016/j.ydbio.2008.01.035populating the branchial arches are determined by signaling
interactionswith the surrounding tissues, including the endoderm
of the foregut and the epithelium (reviewed by Chai andMaxson,
2006; Le Douarin et al., 2004; Santagati and Rijli, 2003).
Candidate signaling molecules involved in the morphogen-
esis of the mandibular processes include members of the
fibroblast growth factor family (FGFs), bone morphogenetic
factors (BMPs), transforming growth factors (TGFs), members
of the wingless family (WNTs) and Sonic hedgehog (Shh)
(reviewed by Chai and Maxson, 2006; Francis-West et al.,
2003; Mina, 2001; Richman and Lee, 2003; Santagati and Rijli,
2003; Tapadia et al., 2005).
FGFs represent a family of conserved signaling molecules
that have been implicated in various aspects of vertebrate
craniofacial development (reviewed by Ellsworth et al., 2002;
Nie et al., 2006; Ornitz, 2005; Ornitz and Marie, 2002). Several
FGF and FGF receptors are expressed in the mandibular
epithelium and mesenchyme (reviewed by Nie et al., 2006).
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FGFR signaling have revealed essential roles of FGF signaling
in several aspects of mandibular morphogenesis, including
mediating growth-promoting epithelial–mesenchymal interac-
tions, formation of pharyngeal pouches, and survival of
mandibular mesenchyme (reviewed by Nie et al., 2006).
Loss-of-function analysis of FGF8 provided clear evidence
for its involvement in mandibular morphogenesis. Deletion of
Fgf8 from the mandibular epithelium (Trumpp et al., 1999)
and decreased dosage of FGF8 in mice containing hypomorphic
alleles of Fgf8 (Abu-Issa et al., 2002; Frank et al., 2002;Macatee
et al., 2003) resulted in formation of a smaller mandible,
extensive apoptosis in mandibular mesenchyme, and loss of
skeletal elements in the caudal region of the mandible including
the jaw articulation. Studies in zebrafish provided further
evidence for the roles of FGF signaling in the formation and
patterning of pharyngeal pouches and cartilages in the branchial
arches (Crump et al., 2004a,b; David et al., 2002; Nissen et al.,
2003; Trokovic et al., 2003; Walshe and Mason, 2003). Studies
in chick embryos showed roles of FGF signaling in various
aspects of mandibular morphogenesis including the survival of
mesenchyme (Wilson and Tucker, 2004), in mediating epithe-
lial–mesenchymal interactions regulating the outgrowth of the
mandibular mesenchyme and elongation of Meckel's cartilage
(Mina et al., 2002; Richman et al., 1997), and in chondrogenesis
of micromass cultures derived from mandibular mesenchyme
(Bobick and Kulyk, 2006; Bobick et al., 2007; Mina et al.,
2002). Although these results indicate essential roles of FGF
signaling in mandibular morphogenesis, there remain questions
regarding which of the FGFRs are involved in the skeletogenic
differentiation of the NCC-derived mandibular mesenchyme.
Development of the chick mandibular processes presents an
excellent experimental system to gain further insight into roles of
FGF/FGFR signaling in skeletogenesis of NCC-derived man-
dibular mesenchyme. In the chick embryo, the mandibular pro-
cesses are recognizable at HH15 (E2.5). The formation of
Meckel's cartilage starts with the chondrogenic condensations at
around HH25/26 (E5). Later at around HH28 (E6) cells within
the chondrogenic condensations differentiate into chondrocytes
and begin synthesis and secretion of cartilage-specific extra-
cellular matrix proteins, such as aggrecan and type II collagen.
Chondrogenic differentiation in the developing mandible occurs
in a caudal to rostral gradient, i.e. it begins in the caudal region
and later extends into the more rostral region (Miyake et al.,
1996; Mina et al., 2007).
The chick mandible contains six bones (angular, supra-
angular, articular, splenial, dentary, and mentomandibular) that
are formed in a caudal to rostral gradient by intramembranous
ossification (Mina et al., 2007). The formation of the osteogenic
condensations occurs at around HH31 (E7–7.5) and miner-
alization of the mandibular bones at HH34 (E8). By HH36
(E10), the mandibular processes contain a fully differentiated
Meckel's cartilage surrounded by six mandibular bones (Mina
et al., 2007).
The prominent expression of Fgfr2 and Fgfr3 in osteogenic
and chondrogenic tissue suggests essential functions for these
receptors during chondrogenesis and osteogenesis in the man-dibular arch. Fgfr2 and Fgfr3 are expressed throughout all
phases of chick mandibular skeletogenesis (Havens et al., 2006;
Mina et al., 2002; Wilke et al., 1997). Initially, these receptors
are expressed in mesenchymal condensations giving rise to
Meckel's cartilage and various bones. Later, Fgfr2 and Fgfr3
are expressed in the differentiating Meckel's cartilage and in
the osteoblasts and periosteal tissues of the mandibular bones
(Supplemental Fig. 1).
To address the functions of FGFR2 and FGFR3 signaling
during mandibular skeletogenesis, we over-expressed in the
developing chick mandible, replication-competent retroviruses
carrying truncated FGFR2c or FGFR3c that function as
dominant negative receptors (RCAS-dnFGFR2 and RCAS-
dnFGFR3). Our results demonstrate that FGFR3 signaling is
required for the elongation of Meckel's cartilage, and FGFR2
and FGFR3 have roles during intramembranous ossification of
mandibular bones.
Materials and methods
Viral constructs and stocks
The dominant-negative FGFR3c construct (RCAS-dnFGFR3) encoding aa
1–401 and containing a carboxy-terminal c-myc epitope tag was constructed by
deletion of sequences past the transmembrane domain as described (Velonis et
al., 2004). A viral construct containing a kinase deleted form of chick FGFR2c
(RCAS-dnFGFR2) encoding aa 1–475 with a carboxy-terminal hemagglutinin
(HA) epitope tag (Ratisoontorn et al., 2003) was kindly provided by Dr. Hyun-
Duck Nah. Aviral construct containing the coding sequence of green fluorescent
protein (GFP) (RCAS-GFP) was used as a control (Erceg et al., 2003).
Retroviral titers of about 109 pfu/ml were prepared from a chick embryonic
fibroblast cell line (DF-1) infected with various retrovirus vectors as described
(Ferrari et al., 1999; Morgan and Fekete, 1996) and used for all experiments.
Antibodies
AMV-3C2 antibody (Developmental Studies Hybridoma Bank) that
recognizes retroviral Gag protein p19 was used to visualize cells infected
with RCAS virus (Potts et al., 1987). Mouse monoclonal anti-myc (9E10,
Sigma) was used to detect expression of myc-tagged dnFGFR3 protein. Mouse
monoclonal anti-HA antibodies (HA.11, Covance; F-7, Santa Cruz Biotech-
nology) were used to detect expression of HA-tagged dnFGFR2 protein by
immunohistochemistry and Western blot analysis respectively. A rabbit
polyclonal anti-phosphorylated histone 3 (H3-p) antibody (Ser10, Upstate
Biotechnologies) was used to identify mitotic cells (Hendzel et al., 1997).
Western blot analysis
DF-1 cells were infected with 106 cfu/ml of the different viral constructs and
cultured for 4 days. Cell lysates and Western blot analysis were performed as
previously described with minor modifications (Oliver et al., 1994). Lysates
containing equivalent protein (40 μg) were mixed with SDS-PAGE loading
buffer, resolved on 12% SDS-PAGE, and electro-transferred to Immobilon-P
membranes (Millipore Corp). Membranes were incubated for 2 h with anti-myc,
or anti-HA antibodies at a concentration of 10 μg/ml, and then for 30 min with a
1:10,000 dilution of horseradish-peroxidase linked anti-mouse secondary
antibody (Amersham). Immunoblots were developed using enhanced chemilu-
minescence (Amersham).
Mitogenic assay
DF-1 cells were infected for 1 week with 106 pfu/ml of various viral
constructs. The efficiency of the infection was examined by immunocytochem-
istry using anti-myc (1:2000 dilution) and anti-HA (1:2500 dilution) antibodies.
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in DMEMmedium containing 10% Fetal Calf Serum (FCS). After 24 h, cultures
were changed to medium containing 1% FBS and then grown in the presence or
absence of 20 ng/ml FGF2 (R&D Systems) and 10 mg/ml heparin (Sigma).
After 48 h, attached cells were harvested with trypsin/EDTA and counted with a
Coulter Counter. For each construct, the percent increase in the number of
attached cells in response to FGF2 was determined relative to that in cells grown
in the absence of FGF2. Values represent the mean±S.E. from duplicated
cultures in at least two independent experiments.
Tissue fixation and processing
Tissue fragments were fixed in freshly prepared 4% paraformaldehyde in
PBS at 4 °C overnight, and micromass cultures were fixed in 4% paraformalde-
hyde for 10 min and scraped from the culture dishes. All fixed tissues were
dehydrated and processed for paraffin embedding. Seven μm sections were
mounted on Probe-On Plus slides and processed for various analyses.
Immunohistochemistry
Immunohistochemistry was performed on paraffin embedded sections.
Sections were quenched in 1% H2O2 and incubated with Target Retrieval
Solution (DakoCytomation) for 20 min at 95 °C. Slides were incubated with
blocking solution and then with primary antibodies (AMV-3C2: 1/100, 9E10: 1/
4000, HA.11: 1/1000, Ser10: 1/1000) overnight at 4 °C. Slides were rinsed and
incubated for 30 min at room temperature with a 1:200 dilution of secondary
biotinylated horse-anti-mouse or goat-anti-rabbit antibodies followed by a
30 min incubation with avidin-biotinylated horseradish peroxidase (Vector
Labs). 3-3′-Diaminobenzidine (DAB Substrate Kit, Vector Labs) was used as
the substrate for horseradish peroxidase.
Chicken embryos and microinjections
Fertilized pathogen-free white leghorn chick eggs (SPAFAS; Charles River
Laboratories) were incubated at 37.5 °C in a humidified incubator and embryos
were staged according to Hamburger and Hamilton (HH) (Hamburger and
Hamilton, 1951). At desired stages of development (HH15–26, embryonic days
E2.5–E5), eggs were windowed and the right side of the face or right forelimb
was exposed by removing the vitelline membrane. Concentrated virus was
thawed and mixed with 4% (v/v) fast green as a tracer dye to visualize the region
of microinjection. Injections were performed using pulled glass capillary
pipettes attached to a Narishinge microinjector. After injection, 1–2 drops of
antibiotic/antimycotic were added on top of the membrane, eggs were sealed and
returned to the incubator for various times (Morgan and Fekete, 1996).
Skeletal whole-mount staining and analysis
Embryos were processed for staining with Alcian blue and alizarin red as
previously described (Wang et al., 1998).
In situ hybridization to whole-mounts and sections
Whole-mount hybridization using digoxigenin-labeled RNA probes and
hybridization to tissue sections using 32P-labeled antisense RNA probes were
performed as previously described (Mina et al., 2002). The cDNAs for this
study included Fgfr2 and Fgfr3 (Mina et al., 2002), Sox9 (Healy et al., 1999),
dHand (Srivastava et al., 1995), Barx1 (Barlow et al., 1999), Dlx5 (Ferrari et al.,
1999), Msx1 (Mina et al., 1995), PTH-1R (Vortkamp et al., 1996), Runx2
(Stricker et al., 2002), Osteocalcin (Neugebauer et al., 1995) and aggrecan core
protein (Mina et al., 2007). Individuals who kindly provided these cDNAs
include Drs. C. Healy (Sox9), D. Srivastava (dHand), P. Francis-West (Barx1),
R. Kosher (Dlx5), C. Tabin (PTH-1R), S. Sticker (Runx2), L. Gerstenfeld
(Osteocalcin), and M. Tanzer (aggrecan). Following in situ hybridization, the
sections were stained with hematoxylin or toluidine blue and mounted with
Permount. Using Adobe Photoshop 7.0 software, the silver grains in the dark-
field image were selected, colored red, and then superimposed onto the bright-
field images.Cell proliferation and apoptosis assays
For analysis of cell proliferation, mandibles were fixed 2 to 6 days after
injection and subjected to immunohistochemistry with an H3-p antibody as
described above. An in Situ Cell Death Detection Kit (Roche) was used to detect
apoptotic cells in sections adjacent to those used for analysis of cell proliferation
in each mandible. For quantitative analysis, equivalently defined areas on the
injected and uninjected sides were outlined and measured using ImageJ
software. Defined areas after injection between HH17 and 20, included the
entire area of the mandibular mesenchyme at day 2 (8–12 sections), the area of
newly formed Meckel's cartilage (defined by Alcian blue staining and
morphological criteria) at day 3 (6 sections), different regions of differentiated
Meckel's cartilage at day 4 (rostral, middle and caudal third) (10–12
longitudinal and 13–15 cross sections), and the condensation for the supra-
angular bone at day 4 as defined by proximity to the caudal region of Meckel's
cartilage (8–17 sections). The cell proliferation and apoptosis in differentiated
angular bone was measured in 8–13 sections 6 days after injection at HH26. In
each defined area, H3-p positive and TUNEL-positive cells were individually
counted using ImageJ. Values for cell proliferation and apoptosis represent the
mean±S.E. of positively stained cells/mm2 that were determined from 6–
17 sections (described above) from at least four different embryos at each time
point.
Micromass cultures and analyses
Micromass cultures were prepared from the mandibular mesenchyme of
HH23 pathogen-free chick embryos as previously described (Mina et al., 1991).
Infection of micromass cultures was carried out as previously described
(Lizarraga et al., 2002) with some modifications. Briefly, before plating,
dissociated cells (1.5×107 cells/ml) were incubated in medium with 10% FCS
containing 2.5×109 pfu/ml of various viruses at 37 °C for 2 h. The cells were
then plated as 20 μl spots in the center of 4 well plates. After 2 h, media
containing a 60:40 ratio of F12/DMEM, 2% fetal calf serum, 2 mM glutamine,
200 μg/ml ascorbic acid, 100 units/ml penicillin, 100 μg/ml streptomycin,
0.25 μg/ml fungizone and 108 pfu/ml of viruses was added. The accumulation of
cartilage matrix was monitored histochemically by staining with Alcian blue
(Mina et al., 1991), and was quantified after extraction of Alcian blue
spectrophotometrically using an ELISA reader with a 630 nm filter (Hassell and
Horigan, 1982; Meyer et al., 2001). Histochemical staining for Peanut agglutinin
(PNA), was performed as previously described (Gehris et al., 1997) with 100 μg/
ml peroxidase-conjugated PNA (Sigma) and a DAB substrate kit (Vector
Laboratories). The areas of cultures stained with PNA and Alcian blue were
quantified using the Color Range and Histogram commands in Adobe
Photoshop (version 7.0) on images acquired under identical exposure and
lighting conditions. To determine the ratio of PNA to Alcian blue staining in
each culture, PNA stained cultures were restained with Alcian blue. Values for
all micromass experiments represent mean±S.E. determined from triplicate
cultures in at least two independent experiments.
Statistical analysis
Unpaired, two-tailed t-tests were performed to determine statistically
significance differences and pb0.01 was considered statistically significant.
Results
Characterization of dominant negative FGFR3 construct in
vitro
Western blot analysis of DF-1 cells infected with RCAS-
dnFGFR3 using anti-myc antibody showed the presence of an
intact protein product of approximately 82 kDa (Supplemental
Fig. 2A). Antibody staining showed the expression of myc-
tagged protein in greater than 80% of the DF-1 cells infected for
4 days with RCAS-dnFGFR3 (data not shown).
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transduction, its ability to inhibit the mitogenic response of DF-
1 cells to FGF2 was examined. FGF2 induced increases in the
number of cells in cultures of uninfected cells and cells infected
with control virus (Supplemental Fig. 2C). In cultures infected
with RCAS-dnFGFR3, FGF2 treatment resulted in a markedly
reduced mitogenic response (Supplemental Fig. 2C) indicating
that this construct acts as a dominant-negative receptor.
dnFGFR3 affected mandibular morphogenesis
To assess the effects of blocking FGFR3 signaling on
mandibular morphogenesis, RCAS-dnFGFR3 or control viruses
were injected into the right half of the mandible of chickFig. 1. Effects of over-expression of dnFGFR3 and dnFGFR2 on skeletal developmen
of control virus (A), or RCAS-dnFGFR3 (B–D) into the right mandibular process at H
mandible injected with control virus at HH17/18, showing that skeletogenesis on the
mandible injected with dnFGFR3 at HH17/18 showing severe truncation of Mecke
mentomandibular bone (Me) on the injected side. Also note the alterations in the posit
the injected side. (C) A mandible injected with dnFGFR3 at HH26 showing the ab
articular, supra-angular, and mentomandibular bones. (D) Schematic drawing illust
Inferior view of a skeletal preparation of a head at HH37 after injection of RCAS-dn
and the injected side is on the left of the picture. On the injected side, the maxillary, p
bones are smaller than those on the uninjected side. The frontal and nasal bones were
drawing illustrating the effects of the dnFGFR3 on the upper beak shown in panel E.
defects in the developingMeckel's cartilage and smaller articular, angular, supra-angu
with RCAS-dnFGFR2 at HH19–20 (left) and the contra-lateral uninjected limb (right
the uninjected limb. Also note the shortening of the humerus, radius, ulna, and p
(indicated by dashed lines), radius, and ulna, and a lack of ossification in most phala
An=angular, Ar=articular, De=dentary, F=frontal, Hu=humerus, J= jugal, MC
Ph=phalanges, Pl=palatal, Pm=premaxillary, Pt=Pterygoid, Qi=quadratojugal, Raembryos at early (between HH15 and 20) and later (HH 26)
stages of development.
We first examined the onset and the extent of viral
infection and the expression of dnFGFR3 in the developing
mandible. In embryos injected at early stages of development,
expression of viral Gag and myc-tagged dnFGFR3 was
detected in the injected side in a high percentage of the cells
at 1 day and in the majority of cells at 2 days (Fig. 3B). At 1
and 2 days post-injection, Gag expression was detected at
higher levels and in a higher percentage of cells including the
chondrogenic mesenchyme as compared to myc-tagged
dnFGFR3 (data not shown). At 4 days, Gag and dnFGFR3
were expressed in the mandibular epithelium and most of the
mandibular mesenchyme including the chondrocytes oft. (A–D)Whole-mount skeletal preparation of mandibles at HH37 after injection
H17/18 (B) or HH26 (C, D). In all pictures, the injected side is on the left. (A) A
injected side of the mandible is indistinguishable from the uninjected side. (B) A
l's cartilage, absence of five mandibular bones and the formation of a smaller
ion and shape of the elements in the articulating end of the Meckel's cartilage on
sence of the angular, splenial, and dentary bones and the formation of smaller
rating the effects of dnFGFR3 injected at HH26 on the developing bones. (E)
FGFR3 into the maxillary process at HH17/18. The mandible has been removed
alatal and jugal bones are absent. The premaxillary, quadratojugal and pterygoid
unaffected and were lost on the uninjected side during dissection. (F) Schematic
(G) A mandible injected with dnFGFR2 at HH17/18 showing the lack of severe
lar, and splenial bones. (H) Skeletal preparation at HH37 of the forelimb injected
) from the same embryo. Note the shortening of the injected limb as compared to
halanges, shortened ossified regions stained with Alizarin red of the humerus
nges (indicated by arrow) in the injected limb. Scale bars in all pictures=1 mm.
=Meckel's cartilage, Me=mentomandibular, Mx=maxillary, N=nasal bone,
= radius, Sa=supra-angular, Sp=splenial, and Ul=ulna.
Fig. 2. Effects of dnFGFR3 on mandibular outgrowth, initial formation of MC and on the expression of transcription factors in the developing mandible. (A) Inferior
view of a chicken head at HH37 injected with RCAS-dnFGFR3 at HH17/18. (B) Frontal view of a chicken head at HH28–29 injected with RCAS-dnFGFR3 at
HH17/18. (C) Alcian blue preparation of the mandible from the embryo in panel B. The injected sides of the mandible are on the left. Note the severe deviation of
the mandible (indicated by arrow) towards the injected side at HH37 (8 days after injection). Also note the detectable deviation in the midline of the lower jaw from
the upper jaw (indicated by dashed lines in panel B) and the reduced length of Meckel's cartilage (C) on the injected side. Scale bars=1 mm. Panels D–G are frontal
views of whole-mount in situ hybridization analysis for Msx1 (D), dHand (E), Barx1 (F), and Dlx5 (G) in the mandibular processes 2 days after injection of
RCAS-dnFGFR3 at HH17/18. In all pictures, the injected side of the mandible is on the left. There are no detectable changes in the domains and levels of expression
of these transcription factors on the injected sides of the mandible compared to the uninjected sides. Scale bars=500 μm.
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the tongue (Supplementary Figs. 3A–C and data not shown).
At 4 days after injection at later stages of development,
expression of Gag and myc-tagged dnFGFR3 were detected
in most of the undifferentiated mandibular mesenchyme,
small clusters of chondrocytes in Meckel's cartilage, and the
majority (but not all) of the osteoblasts in the mandibular
bones in the injected side (data not shown). Thus, injections
at early stages resulted in widespread infection throughout the
injected side of mandible, whereas injection at later stages
resulted in more localized and limited infections.
Next we examined the effects of dnFGFR3 during
mandibular morphogenesis. We have recently reported that
injection of dnFGFR3 resulted in stage and region specific
abnormalities in the outgrowth of the developing mandible,
morphogenesis of the Meckel's cartilage and mandibular bones
(Mina et al., 2007). Injection between HH17 and 20 led to
severe defects in mandibular outgrowth (Figs. 1B and 2A), a
high frequency of truncation of the rostral end and shortening of
Meckel's cartilage (83%, n=6, Fig. 1B), and high frequency ofTable 1
Changes in the mandibular bones after injection of RCAS-dnFGFR3 and RCAS-dn
Construct Stage injected Articular Angular
S A S A
dnFGFR3 17–20 (n=26) 27 73 19 81
26 (n=16) 100 0 94 6
dnFGFR2 17–20 (n=24) 92 0 79 0
Percentage of various abnormalities in the mandibular bones in HH37 embryos fol
development.
S denotes the percentage of bones that were smaller. A denotes the percentage of bon
rostral order from left to right.absence of five of the mandibular bones (Fig. 1B and Table 1).
We also noted alterations in the position and shape of the
elements in the articulating end of the Meckel's cartilage on the
injected side (Fig. 1B). Injections of either RCAS-dnFGFR3 or
control viruses at HH15 resulted in a low survival rate.
Surviving embryos injected with RCAS-dnFGFR3 displayed
defects in mandibular outgrowth similar to those after injection
at HH17–20 (data not shown). Injection at later stages did not
affect the morphogenesis of Meckel's cartilage (Fig. 1C),
caused only mild defects in mandibular outgrowth in a small
percentage of embryos (Mina et al., 2007), and led to the
formation of five smaller than normal mandibular bones (Figs.
1C, D and Table 1). Mandibular morphogenesis on the
injected side of the embryos injected with control viruses
(n=24) was indistinguishable from the uninjected side (Fig.
1A), indicating that virus injection itself does not disturb
mandibular morphogenesis.
As injections of RCAS-dnFGFR3 between HH17 and 20 had
high survival rates and displayed the most consistent and severe
abnormalities in the outgrowth of the mandibular process andFGFR2
Supra-
angular
Dentary Splenial Mento-
mandibular
S A S A S A S A
12 88 23 77 4 96 88 4
94 6 75 25 44 56 81 0
79 0 0 0 79 0 0 0
lowing injections of RCAS-dnFGFR3 or RCAS-dnFGFR2 at various stages of
es that were absent. The six mandibular bones are arranged in a general caudal to
341B.A. Havens et al. / Developmental Biology 316 (2008) 336–349Meckel's cartilage, further characterization of the underlying
mechanisms leading to abnormalities in Meckel's cartilage was
investigated in this group.
dnFGFR3 did not affect the early patterning of the developing
mandible
The earliest detectable defects in the growth of the
mandibular processes after injection at early stages were
noted 3 days after injections (Fig. 2B), suggesting that defects
are related to alterations in expression of components of
signaling pathways regulating mandibular outgrowth.
To investigate this possibility we examined the expression of
a selected number of transcription factors known to be
downstream of signaling pathways regulating mandibular
patterning. However, whole mount in situ hybridization
revealed no noticeable changes in the intensity and domain of
expression of these transcription factors on the injected sides
compared to the uninjected sides at 2 and 3 days after injections
(Figs. 2D–G and data not shown). These results show that
defects in mandibular outgrowth are not related to compromised
integrity of the NCC population in the mandibular mesench-
yme, nor to alterations in early signaling activities regulating
mandibular outgrowth.Fig. 3. Effects of dnFGFR3 on the expression of markers of chondrogenesis in Mecke
I, L) and Aggrecan (E, H, K) and immunohistochemical detection of Gag (B, G, J,
injection of dnFGFR3 into the right half of the developing mandible at HH17/18. In
through a mandible 2 days after injection showing the reductions in the domain of ex
antibody to Gag showing the extensive expression of Gag in the mesenchyme on the i
showing the reductions in the domain of expression of Sox9 on the injected side (C) a
the caudal region of the mandible showing the unchanged patterns of expression o
expression of Gag is shown in an adjacent section (G). (H–J) are adjacent cross sectio
and levels of expression of Aggrecan (F) and Sox9 (G) in Meckel's cartilage in the in
Gag antibody. Panels K–M are adjacent cross sections through the rostral region of th
domain and level of Sox9 (L) in Meckel's cartilage on the injected side. Panel M is an
bars in all pictures=100 μm.dnFGFR3 affected cell survival, proliferation and
differentiation during chondrogenesis of Meckel's cartilage
The unchanged patterns of expression of regulatory genes in
the treated side suggested that the truncation of the developing
mandible may be related to the abnormality in Meckel's
cartilage that in turn regulates mandibular outgrowth. Thus, we
next studied the effects of dnFGFR3 on the formation and
morphogenesis of Meckel's cartilage by examining the patterns
of expression of markers of early (Sox9) and late (Aggrecan)
stages of chondrogenesis, and changes in apoptosis and cell
proliferation in the injected and uninjected sides.
At 2 days after injection, at the time of the formation of
chondrogenic condensations, there were noticeable decreases in
the domain and intensity of expression of Sox9 on the injected
sides (Figs. 3A and B), indicating that dnFGFR3 led to the
formation of a smaller chondrogenic condensation. Analysis of
cell proliferation showed no differences in the number and
distribution of proliferating cells in the mandibular mesench-
yme in the injected and uninjected sides (Table 2). In contrast,
TUNEL analysis showed a two-fold increase in the number of
apoptotic cells in the mesenchyme on the injected side (Table
2). Apoptotic cells were detected in the area of the chondrogenic
condensation (Fig. 4A) suggesting that the formation of smallerl's cartilage. Pseudo colored images of in situ hybridization of Sox9 (A, C, D, F,
M) on sections from the developing mandible 2 (A, B) and 3 (C–M) days after
all pictures the injected side of the mandible is on the left. (A) Sagittal section
pression of Sox9 on the injected side. Panel B is a sagittal section incubated with
njected side. (C and D) Sagittal sections through mandibles 3 days after injection
s compared to the uninjected side (D). (E–G) are adjacent cross sections through
f Aggrecan (E) and Sox9 (F) in Meckel's cartilage on the injected sides. The
ns through the middle region of the mandible showing decreases in the domains
jected sides. (J) is an adjacent section processed for immunohistochemistry with
e mandible showing the lack of expression of Aggrecan (K) and decreases in the
adjacent section processed for immunohistochemistry with Gag antibody. Scale
Table 2
Quantitative analysis of the effects of dnFGFR3 on proliferation and apoptosis during chondrogenesis of Meckel's cartilage and osteogenesis of supra-angular and
angular bones
Stage of
injection
Region of analysis Time of analysis
(days after injection)
H3-p positive (cells/mm2) TUNEL positive (cells/mm2)
Injected Uninjected Injected Uninjected
HH17/18 Mandibular mesenchyme 2 308.0±6.8 307.0±8.4 65.5±7.6* 29.7±2.0
HH17/18 Newly formed Meckel's cartilage 3 143.3±9.3* 283.7±17.9 174.6±10.1* 41.6±6.7
HH17/18 Rostral third of Meckel's cartilage 4 287.4±26.3 341.7±21.1* 0 0
HH17/18 Middle third of Meckel's cartilage 4 246.4±18.7 221.4±12.1 0 0
HH17/18 Caudal third of Meckel's cartilage 4 253.9±19.1 249.9±13.2 0 0
HH17/18 Osteogenic condensation for supra-angular bone 4 27.3±1.5 55.6±1.9 24.8±3.9 13.9±2.1
HH26 Differentiated angular bone 6 88.0±7.8* 115.4±7.2 122.2±15.8* 72±7.6
Quantification of H3-p positive cells and TUNEL positive cells was performed as described in Materials and methods. The areas for quantitative analysis included the
entire area of the mandibular mesenchyme (shown in Fig. 4A), newly formed cartilage (outlined in Fig. 4B), osteogenic condensation for supra-angular bone (outlined
in Fig. 5A) and differentiated angular bone (outlined in Figs. 4C–F and 5C–E). All values represent means±S.E. of proliferative and apoptotic cells/mm2 in 6–
17 sections (described in Materials and methods) in 4 independent experiments. Asterisks indicate a statistically significant difference (pb0.01).
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increased apoptosis.
Analysis at 3 days after injection (after the onset of
chondrogenesis and during the elongation of Meckel's
cartilage) showed marked region-specific changes in expression
of Sox9 and aggrecan along the caudal–rostral axis of Meckel'sFig. 4. Effects of dnFGFR3 on the distribution of proliferative and apoptotic cells in
side of the mandible is on the left. (A) is a sagittal section through a mandible 2 days
Note the increased number of apoptotic cells in the area of the chondrogenic conde
through a mandible 3 days after injection of RCAS-dnFGFR3 at HH17/18 processed
proliferative cells in the newly formed MC (outlined by dashed lines) on the injecte
dashed lines) 6 days after injection of RCAS-dnFGFR3 at HH26 processed for TUNE
F). Note the increases in the number of apoptotic cells in osteoblasts and periosteum
side (D). Also note the reduced number of proliferative cells in the periosteum (indic
Sections B, C, and D were counterstained with Alcian blue to identify Meckel's ca
infected for 4 days with control virus (G) or RCAS-dnFGFR3 (H). Cultures were proc
staining in cultures infected with RCAS-dnFGFR3 (H) compared to cultures infected w
stained with hematoxylin. Scale bars in panel G and H=1 mm.cartilage on the injected side (Figs. 3C–M). The middle and
rostral/growing ends of the newly formed Meckel's cartilage on
the injected side showed noticeable changes in the domain and
intensity of Sox9 and aggrecan expression (Figs. 3H–M). On
the other hand, the patterns of aggrecan and Sox9 expression in
the caudal region were indistinguishable from the uninjectedmandibular mesenchyme and in vitro chondrogenesis. In all pictures the injected
after injection of RCAS-dnFGFR3 at HH17/18 processed for TUNEL staining.
nsation (indicated by arrows) on the injected side. Panel B is a sagittal section
for immunohistochemistry with an H3-p antibody. Note the decreased number of
d side. (C–F) are adjacent cross sections through the angular bone (outlined by
L staining (C and D) and immunohistochemistry with an H3-p antibody (E and
(indicated by arrowhead) on the injected side (C) as compared to the uninjected
ated by arrows) on the injected side (E) as compared to the uninjected side (F).
rtilage. Scale bars in panels A–F=200 μm. (G and H) are micromass cultures
essed for Alcian blue and hematoxylin staining. Note the decreases in Alcian blue
ith control virus (G). The arrows outline the periphery of the micromass cultures
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different levels along the rostral–caudal axis (Figs. 3G, J, M)
indicated that the lack of abnormalities in cartilage differentia-
tion in the caudal region is related to a more advanced stage of
differentiation of cartilage at the time of peak infection. In the
middle region, the decrease in the domain of aggrecan
expression (Fig. 3H) was more noticeable than Sox9 (Fig. 3I)
indicating the negative effects of dnFGFR3 on differentiation of
Sox9-expressing cells. Rostral/growing ends of Meckel's
cartilage on the injected side showed decreases in the intensity
and domain of Sox9 expression and a lack of aggrecan
expression (Figs. 3K–M) showing the negative effects of
dnFGFR3 on differentiation of Sox9-expressing cells in the
growing end, leading to the formation of truncated/shortened
Meckel's cartilage (Fig. 1B). Analysis of cell proliferation and
apoptosis showed a 50% decrease in the number of proliferative
cells and a greater than four-fold increase in the number of
apoptotic cells in the newly formed Meckel's cartilage in the
injected sides (Table 2, Fig. 4B), revealing the roles of FGF/
FGFR3 on proliferation and survival of the chondroblasts in
Meckel's cartilage.
The roles of FGF/FGFR3 on the proliferation of chondro-
blasts and the elongation of Meckel's cartilage were further
supported by decreases in the number of proliferative
chondroblasts in the rostral/growing end of the Meckel's
cartilage on the injected side 4 days after injection. The rostral
region of Meckel's cartilage on the uninjected side contained a
significantly greater number (55%) of proliferative chondro-
blasts compared to the middle and caudal regions (Table 2). In
contrast, the number of proliferative chondroblasts in the rostral
end of the Meckel's cartilage on the injected side was
comparable to those in the middle and caudal regions and
decreased as compared to the uninjected side (Table 2).
Apoptotic cells were not detected in Meckel's cartilage in
either the injected or uninjected sides (Table 2). However, there
was a greater than three-fold increase in the number of apoptotic
cells in the mesenchyme rostral to the growing end of Meckel's
cartilage on the injected sides (196.6±10.9) compared to the
uninjected side (58.9±13.3).
Together these observations show roles for FGF/FGFR3
signaling in proliferation, survival and overt differentiation of
Sox9-expressing chondro-progenitors and chondroblasts in
Meckel's cartilage.Table 3
Quantification of the effects dnFGFR3 on in vitro chondrogenesis of mandibular me
Analysis Days RCAS
# of aggregates 2 134.3±17.3
Size of aggregates (mm2) 2 0.05±0.009
Relative absorbance 4 117.9±6.3 (
6 160.0±6.1 (
Relative area stained by Alcian blue 4 8.46±0.33
6 10.67±0.27
PNA/Alcian blue 3 1.07±0.01
4 1.12±0.02
The quantification of various parameters was determined as described in Materials
parenthesis) in two or three independent experiments. ND, not determined. AsteriskdnFGFR3 affected in vitro chondrogenesis
The role of FGF/FGFR3 signaling in chondrogenesis by the
mandibular mesenchyme was further examined in high-density
micromass cultures derived from HH23 mandibular mesench-
yme. This culture system allows the formation of chondrogenic
condensations and differentiation, and is a useful tool for
examining the roles of signaling pathways during various stages
of chondrogenesis.
Immunohistochemical analysis showed Gag and dnFGFR3
positive cells within cartilaginous nodules and in the inter-
nodular regions (Supplemental Figs. 3E, F). Infection with
RCAS-dnFGFR3 resulted in reduced chondrogenesis as
demonstrated by significant decreases in the area and the
amount of Alcian blue-stained matrix (Figs. 4G, H and Table 3).
The decreases in chondrogenic differentiation were not related
to decreases in the size of cultures, as the total area of
micromass cultures was comparable among cultures infected
with control virus and RCAS-dnFGFR3 (Figs. 4G and H).
Infection with control virus did not affect chondrogenesis of
mandibular mesenchyme as compared to uninfected cultures
(data not shown). The reduced chondrogenesis in high density
cultures derived from mandibular mesenchyme infected with
dnFGFR3 is consistent with impaired chondrogenesis in
micromass cultures from Fgfr3−/− limb buds (Davidson et
al., 2005).
The effects of dnFGFR3 on chondrogenic condensation in
vitro was examined by staining with PNA, a lectin that
selectively binds a cell surface marker(s) on condensing
mesenchyme (Zimmermann and Thies, 1984). Cultures infected
with RCAS-dnFGFR3 showed decreases in the number, but not
the size of PNA-positive chondrogenic condensations compared
to cultures infected with control RCAS (Table 3). Morphometric
analysis of cartilage nodules in cultures stained with both PNA
and Alcian blue showed increases in the ratio of PNA to Alcian
blue staining in cultures infected with dnFGFR3 compared to
control virus (Table 3), showing the negative effects of
dnFGFR3 on differentiation of the PNA-positive cells at the
periphery of the micromass cultures. In cultures infected with
control virus, nearly the entire area of the cartilage nodules
stained with Alcian blue, whereas in cultures infected with
RCAS-dnFGFR3, Alcian blue-stained cartilage nodules were
surrounded by PNA-positive cells on the periphery (not shown).senchyme
RCAS-dnFGFR3 RCAS-dnFGFR2
(n=6) 111±5.5 (n=6) ND
(n=6) 0.045±0.005 (n=6) ND
n=16) 73.8±2.0* (n=12) 105.8±4.5 (n=12)
n=16) 88.2±8.7* (n=12) 146.3±8.2 (n=12)
(n=16) 5.53±0.14* (n=12) 7.87±0.24 (n=12)
(n=16) 6.24±0.69* (n=12) 10.18±0.67 (n=12)
(n=13) 1.18±0.02* (n=11) ND
(n=10) 1.25±0.11* (n=10) ND
and methods. Values represent the mean±S.E. for 6–12 cultures (indicated in
s indicate statistical significance at pb0.01.
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growth of mandibular bones
Skeletal staining at HH37 showed that all embryos injected
with RCAS-dnFGFR3 displayed abnormalities in five of the
mandibular bones on the injected sides (Table 1 and Figs.
1B–D). Injections at early stages led to absence of bones
(articular, angular, supra-angular, dentary and splenial, Table 1
and Fig. 1B) whereas injection at HH26 led to the formation
of smaller bones in the caudal region (articular, angular,
supra-angular) and absence of the bones in the rostral region
(dentary and splenial bones, Table 1 and Figs. 1C, D). These
abnormalities are consistent with the patterns of expression of
Fgfr3 in the developing mandibular bones. Fgfr3 is initially
expressed in osteogenic condensations and later in the
osteoblasts and periosteal tissues expressing PTH-1R (Supple-
mental Fig. 1).
The difference in the effects of RCAS-dnFGFR3 in the
caudal vs. more rostral bones after injection at later stages is
related to the stage of differentiation of different mandibular
bones along the caudal–rostral axis of the mandible at the time
of peak infection (Mina et al., 2007). The lack of abnormalities
in the mento-mandibular bone after injection of dnFGFR3 at all
stages (Figs. 1B–D, Table 1) suggest that development of the
mento-mandibular bone is not dependent on FGF/FGFR3Fig. 5. Effects of dnFGFR3 on osteogenic condensations and expression of markers
the mandible is on the left. (A and B) are adjacent cross sections through the caudal
HH17/18. Note the absence of morphologically recognizable osteogenic condensatio
to Meckel's cartilage on the injected side of the mandible. (B) Pseudo-colored im
condensations of the supra-angular and angular bones on the uninjected side. PTH
colored images of in situ hybridization for PTH-1R (C, F, G), Runx2 (D, H, I) and
sections through the caudal region of mandible 6 days after injection of RCAS-dnFG
of expression of PTH-1R (C), Runx2 (D) and OC (E) in the angular bones on the inj
note the absence of the supra-angular bone on the injected sides. Figures F–K are
uninjected (G, I, K) sides. Note the marked reduction in the number of PTH-1R
compared to the uninjected sides. Runx2 is expressed in osteoblasts on the uninjecte
the periosteum (indicated by arrows) on the injected and uninjected sides. An=Ansignaling and is dependent on other signaling pathways, such
as the ET-1-dHAND-Msx1 and BMP/Alk2 signaling pathways
shown to play critical roles in the morphogenesis of the medial/
rostral region of the mandible (Dudas et al., 2004; Fukuhara et
al., 2004; Thomas et al., 1998).
To exclude the possibility that the abnormalities in the
mandibular bones were related to severe defects in the
outgrowth of the mandibular process and Meckel's cartilage,
RCAS-dnFGFR3 was injected into the right maxillary process
at early stages (n=8). This treatment did not affect the
outgrowth of the maxillary process but led to the absence of
bones derived from the maxillary process (maxillary bone,
palatal process and jugal bone, Figs. 1E, F).
Next we examined the patterns of expression of early (PTH-
1R and Runx2) and late (Osteocalcin, OC) markers of osteoblast
differentiation, as well as changes in apoptosis and proliferation
in angular and supra-angular bones, as these bones were easily
identifiable in cross sections and were consistently affected after
both early and late injections (Table 1).
Four days after injection at early stages, the region
corresponding to the osteogenic condensations giving rise to
the supra-angular and angular bones on the injected side showed
a lack of expression of both PTH-1R and Runx2 (Fig. 5B and
data not shown), a 51% decrease in the number of proliferative
cells, and an approximately 78% increase in the number ofof osteogenesis in the mandibular bones. In both pictures, the injected side of
region of the mandibular process at HH31 after injection of RCAS-dnFGFR3 at
ns (outlined by dashed lines) for the supra-angular and angular bones adjacent
age of in situ hybridization showing expression of PTH-1R in the osteogenic
-1R is not detected on the injected side. Scale bars=200 μm. (C–K) Pseudo-
OC (E, J, K) in the angular bone (outlined by dashed lines) in adjacent cross
FR3 at HH26. The injected sides of the mandible are on the left. The domains
ected sides of the mandible are smaller than those on the uninjected sides. Also
higher magnification images of the angular bone on the injected (F, H, J) and
and OC expressing osteoblasts in the angular bones on the injected sides as
d side (I), but not on the injected side (H). PTH-1R and Runx2 are expressed in
gular, MC=Meckel's cartilage, and Sa=Supra-angular. Scale bars=200 μm.
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of histological evidence for osteogenic condensation in
Hematoxylin and Eosin stained sections (Fig. 5A) revealed
the essential roles of FGF/FGFR3 on proliferation and survival
of osteo-progenitor cells in osteogenic condensations.
Analyses of the angular bone 6 days after late injection at
HH26 showed significant reductions in the domains of
expression of PTH-1R, Runx2 and OC, a 24% decrease in the
number of proliferating cells, and a 70% increase in apoptosis
compared to the uninjected side (Table 2 and Figs. 5C–K).
Osteoblasts on the injected side expressed PTH-1R and OC, but
low or no detectable Runx2 (Figs. 5C–K). These results showed
that FGF/FGFR3 is essential for proliferation and survival of
osteoblasts and the osteoprogenitors in the periosteum.
Effects of dominant negative FGFR2 on the formation of
MeckelTs cartilage and mandibular osteogenesis
The patterns of expression of Fgfr2 in the developing chick
mandibular skeleton are similar to Fgfr3 (Supplemental Fig. 1),
suggesting the possibility of redundant and/or cooperative roles
for FGFR2c and FGFR3c in the chondrogenesis and osteogen-
esis of the mandibular mesenchyme. The role of FGFR2c-
mediated signaling in the formation and elongation of Meckel's
cartilage and mandibular osteogenesis was examined using a
previously characterized RCAS-dnFGFR2 shown to decrease
proliferation in primary osteoblast cultures (Ratisoontorn et al.,
2003).
Skeletal staining after early injection of RCAS-dnFGFR2
(n=32) revealed the formation of slightly smaller articular,
angular, supra-angular, and splenial bones on the injected side of
90% of the embryos (Fig. 1G, Table 1). The formation of smaller
mandibular bones on the injected sides in our study is consistent
with roles of FGF/FGFR2c in osteoblast proliferation and
differentiation (Eswarakumar et al., 2002; Yu et al., 2003). Mice
lacking the Fgfr2c isoform (Eswarakumar et al., 2002) and
conditional inactivation of Fgfr2 in the osteogenic lineage (Yu et
al., 2003) showed delayed onset of osteoblast differentiation
with decreases in Runx2 expression (Eswarakumar et al., 2002).
However, there were no severe abnormalities in the
outgrowth of the mandibular processes or morphogenesis of
Meckel's cartilage on the injected side (Fig. 1G). Furthermore,
RCAS-dnFGFR2 had no discernable effect on in vitro
chondrogenesis of mandibular mesenchyme (Table 3). The
lack of noticeable abnormalities on in vivo and in vitro
chondrogenesis of mandibular mesenchyme by dnFGFR2 was
not related to unsuccessful infection or inability of dnFGFR2 to
act as a dominant negative receptor. Western blot analysis of
DF-1 cells infected with RCAS-dnFGFR2 showed the presence
of an intact protein product of approximately 82 kDa (Supple-
mental Fig. 2B). Immunohistochemical analysis showed wide-
spread expression of Gag and HA-tagged dnFGFR2 in the
injected side of mandibles and in infected micromass cultures
(Supplemental Figs. 3D, G, H, and data not shown). RCAS-
dnFGFR2 also resulted in a markedly reduced mitogenic
response to FGF2 (Supplemental Fig. 2C). Furthermore,
injection of RCAS-dnFGFR2 in the developing forelimb atHH19–20 (n=7) led to shortening of the entire limb and various
skeletal elements (Fig. 1H). Skeletal preparations at HH37
showed shortened ossified regions in the humerus (4/7), radius
(5/7) and ulna (3/7) in the injected limbs. Other abnormalities
included a lack of osteogenesis in the proximal phalanges and
truncations of the cartilaginous middle and distal phalanges (7/
7) (Fig. 1H). These changes in the developing limb are
consistent with the abnormalities in mice lacking FGFR2c
(Eswarakumar et al., 2002; Yu et al., 2003).
Discussion
Our expression data together with our analysis of the effects
of blocking FGFR3 and FGFR2 signaling on mandibular
skeletogenesis provide new evidence for essential roles of FGF/
FGFR3 signaling in the formation of osteogenic condensations,
and in the morphogenesis and elongation of Meckel's cartilage.
Our study also shows that appositional growth of mandibular
bones is dependent on both FGFR2 and FGFR3 signaling.
Roles for FGF signaling during morphogenesis and elongation
of Meckel's cartilage
Our observations show that blocking FGFR3 signaling in the
developing chick mandible between HH17 and 20 did not affect
the initial formation of Meckel's cartilage but affected further
morphogenesis and the elongation of Meckel's cartilage.
Blocking FGFR3 signaling affected the proliferation, survival
and differentiation of cells within the chondrogenic mesench-
yme and chondroblasts. This provides new evidence for the
essential roles of FGF/FGFR3 signaling during the morphogen-
esis and elongation of Meckel's cartilage.
We have shown that blocking FGFR3 signaling during the
formation of Meckel's cartilage led to the truncation of the
rostral/growing end of the Meckel's cartilage. The effects were
mediated by decreased proliferation of chondroblasts in
Meckel's cartilage and impaired differentiation of Sox9
expressing chondrogenic cells. The essential role of FGFR3
signaling on proliferation of chondrogenic cells in Meckel's
cartilage in chick embryos provides support for mitogenic
effects of FGFR3 signaling on chondroblasts/chondrocytes
during embryonic development. The positive roles of FGFR3
mediated signaling on chondrocyte proliferation and differ-
entiation are different from the negative roles of FGFR3 on
chondrocytes during the postnatal stages of development
(Colvin et al., 1996; Deng et al., 1996; Eswarakumar and
Schlessinger, 2007). Although a comprehensive analysis of
craniofacial defects in Fgfr3−/− and Fgfr3c−/− mice during
embryonic development has not been reported, a lack of
defects in the developing mandible and Meckel's cartilage in
these transgenic mice may not be surprising as the main body
of the Meckel's cartilage in mammals is a transient structure
(Harada and Ishizeki, 1998). The permanent fate of Meckel's
cartilage in birds as compared to its transient fate in mammals
allowed us to gain insight into roles of FGF/FGFR3 in
morphogenesis of Meckel's cartilage. The positive roles of
FGFR3 signaling on proliferation of chondroblasts during early
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findings in transgenic mice carrying an activating mutation in
FGFR3 (Iwata et al., 2000, 2001). These animals displayed
increases in the proliferation of chondroblasts in the growth
plate at E15.5 (Iwata et al., 2000, 2001) and overgrowth of
other hyaline cartilages, including the trachea and nasal septum
(Iwata et al., 2001).
Our observations also show essential roles of FGF/FGFR3
signaling in the survival and differentiation of Sox9-expressing
chondrogenic cells. Sox9 is a transcription factor that is
expressed in chondrogenic mesenchyme with critical roles in
the overt differentiation of chondrocytes and their survival and
proliferation (Lefebvre et al., 1998). Inactivation of Sox9 in
limb buds prior to the formation of chondrogenic condensations
led to an absence of cartilage elements (Akiyama et al., 2002).
Inactivation of Sox9 in condensed mesenchymal cells and
differentiated chondrocytes revealed the essential roles of Sox9
in proliferation, survival and overt differentiation of chondro-
blasts (Akiyama et al., 2002). The truncation of Meckel's
cartilage and the hypoplastic mandibular processes on the
injected side in our study suggest that the effects of FGFR3
signaling on Meckel's cartilage are mediated at least in part
through Sox9. This is further supported by the similarities in the
changes observed in our study and those reported in Sox9−/+
mutant mice (Bi et al., 2001).
The overlapping expression patterns of FGFR2c and
FGFR3c in the chondrogenic condensation and the newly
formed Meckel's cartilage suggest the possibility of coopera-
tive/redundant roles of these receptors in the morphogenesis of
Meckel's cartilage. However, our study shows that despite wide
expression, dnFGFR2 did not affect chondrogenesis and
elongation of Meckel's cartilage in vivo or in vitro, suggesting
dispensable/unessential roles of FGFR2 signaling in this
process. Since the peak expression of dnFGFR2 and dnFGFR3
occurs during the formation of the chondrogenic condensation,
the roles of signaling through these receptors during early stages
of mandibular morphogenesis remains unknown.
Roles for FGF signaling during osteogenesis of the mandibular
bones
The importance of FGFRs in osteogenesis has been
highlighted by the discoveries that gain-of-function point
mutations within the amino acid coding sequences of
FGFRs1–3 are responsible for craniosynostoses syndromes,
characterized by premature fusion of cranial sutures due to
dysregulated intramembranous bone formation (Ornitz and
Marie, 2002). FGFR1 stimulates osteoblast differentiation
(Hajihosseini et al., 2004; Iseki et al., 1999; Zhou et al.,
2000). FGFR2 is involved in regulating osteoblast proliferation
and differentiation (reviewed by Eswarakumar et al., 2005;
Ornitz and Marie, 2002). The formation of mandibular bones
with reduced size after injection of dnFGFR2 is consistent with
essential roles of FGF/FGFR2 signaling in osteoblast prolifera-
tion and differentiation.
Moreover, our results provide new evidence for the essential
roles FGF/FGFR3 signaling in the survival, proliferation anddifferentiation of osteoprogenitors within the osteogenic
condensations and periosteum of the chick mandibular bones.
We show that blocking FGFR3 signaling at early stages of
mandibular development resulted in decreased cell survival and
proliferation and a complete absence of osteogenic mesench-
yme. We also show that blocking FGFR3 signaling at later
stages of mandibular development after the formation of
osteogenic mesenchyme resulted in smaller bones through its
effects on survival and proliferation of osteoblasts and
osteoprogenitor cells within the periosteum, which is respon-
sible for appositional growth of the mandibular bones.
The roles of FGFR3 signaling in mandibular osteogenesis
support the recent observations in several transgenic mouse
models (Ornitz, 2005; Ornitz and Marie, 2002). Transgenic
mice carrying an activating (G375C) mutation in FGFR3
displayed increased expression of markers of osteoblast
differentiation and advanced ossification in the long bones
(Chen et al., 1999). Inhibition of FGFR3 expression by Twist
inhibited the differentiation of osteoprogenitor cells into
osteoblasts (Funato et al., 2001). More recently it has been
shown that young adult Fgfr3−/− and Fgfr3c−/− mice were
osteopenic and displayed decreased thickness of cortical and
trabecular bones (Valverde-Franco et al., 2004; Eswarakumar
and Schlessinger, 2007). In the long bones, cortical bone in the
diaphyses is formed by direct differentiation of osteoprogenitor
cells in the periosteum into osteoblasts, a process that is similar
to intramembranous ossification, providing additional support
for essential roles for FGF/FGFR3 signaling in intramembra-
nous ossification. Interestingly, FGFR3 is detected in sutural
osteogenic fronts (Rice et al., 2000, 2003), and Saethre–
Chotzen syndrome associated craniosynostosis is caused by
mutations in the gene encoding TWIST or FGFR3 (Chun et al.,
2002).
The change in the expression of Runx2 in our study suggests
that the effects of FGF signaling in osteoblasts are mediated
through Runx2. Runx2 is expressed in osteogenic condensations
and acts as an osteoblast differentiation factor (reviewed by
Stein et al., 2004). Runx2 is also expressed in terminally
differentiated osteoblasts, where it directly stimulates transcrip-
tion of osteoblast-related genes (reviewed by Franceschi and
Xiao, 2003; Stein et al., 2004). Runx2 expression and functional
activity are controlled by the mitogen-activated protein kinase
(MAPK) pathway activated by a variety of signals, including
those initiated by FGFs (Franceschi and Xiao, 2003).
However, it is possible that the effects of dnFGFR3 on
mandibular osteogenesis may be indirect and mediated by
regulating angiogenesis. Fgfr3−/− mice showed a down-
regulation of vascular endothelial growth factor (VEGF)
(Amizuka et al., 2004), whereas transgenic mice carrying an
activating mutation in FGFR3 (G380R) displayed premature
and increased vascularization (Cormier et al., 2002; Segev et al.,
2000).
Potential FGF ligands involved in mandibular skeletogenesis
Our observations reveal essential roles of FGFs capable of
binding with high affinity to FGFR3 in the morphogenesis of
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have shown that FGFR3b and FGFR3c isoforms are both
activated by FGF1 and by FGF9 (Ornitz et al., 1996; Zhang et
al., 2006). In addition, FGFs 2, 4, 6, 8 and 18 also bind with
high affinity to FGFR3c (Ornitz et al., 1996; Zhang et al., 2006).
A growing body of evidence indicates that among these
ligands, FGF18 is the most likely physiological ligand for
FGFR3 in both osteogenesis and chondrogenesis (Davidson et
al., 2005; Ellsworth et al., 2002; Liu et al., 2007, 2002;
Ohbayashi et al., 2002; Reinhold et al., 2004). In vitro studies
have shown that FGF18 can bind to and interact strongly with
FGFR3c, moderately with FGFR2c, but not with FGFR1c
(Zhang et al., 2006). Analysis of abnormalities in mice lacking
Fgf18 at different developmental stages has provided evidence
for both positive and negative roles of FGF18/FGFR3 signaling
on chondrocyte proliferation during early and later stages of
development respectively (Liu et al., 2007, 2002; Ohbayashi et
al., 2002). The hypoplastic mandible and shortened Meckel's
cartilage in Fgf18−/− mice (Liu et al., 2007), together with
expression of Fgf18 in the chondrogenic mesenchyme and
perichondrium of Meckel's cartilage in human fetuses (Cormier
et al., 2005), provide support for roles of FGF18/FGFR3
signaling in the morphogenesis and elongation of Meckel's
cartilage.
Fgf18−/− mice also displayed delayed ossification in the
skeletal elements formed by both endochondral and intramem-
branous ossification (Liu et al., 2007, 2002; Ohbayashi et al.,
2002). Young adult Fgf18−/− mice, similar to Fgfr3−/− mice
(Amizuka et al., 2004), were dwarfed, showed decreased
expression of VEGF, Runx2, osteopontin, and osteocalcin
suggesting that the roles of FGF18/FGFR3 in osteogenesis,
including intramembranous ossification of chick mandible in
our study, are indirect.
Specificity of dnFGFR Approach
In a complex system such as the developing mandible with
overlapping patterns of expression of Fgfrs, one possible
explanation of our findings is that the abnormalities caused by
dnFGFR3 are the result of a general dominant-negative effect
by sequestering various FGFs and/or by inhibition of signaling
through other FGFRs. This possibility is difficult to reconcile
with our data as dnFGFR2 led to a markedly milder phenotype,
and there were no changes in the morphogenesis of the tongue
and mandibular muscles, shown to be dependent on signaling
through FGFR1 and FGFR4 (Flanagan-Steet et al., 2000;
Marics et al., 2002). The milder phenotype caused by dnFGFR2
may be caused by heterodimerization of dnFGFR2 with
FGFR3c.
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